- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 37/00 - Drugs for immunological or allergic disorders
Patent holdings for IPC class A61P 37/00
Total number of patents in this class: 8762
10-year publication summary
|
332
|
354
|
491
|
638
|
656
|
605
|
740
|
680
|
601
|
238
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mondobiotech Laboratories AG | 311 |
290 |
| Bristol-myers Squibb Company | 4897 |
146 |
| F. Hoffmann-La Roche AG | 7920 |
131 |
| Novartis AG | 10927 |
119 |
| Genentech, Inc. | 3954 |
75 |
| Incyte Corporation | 1005 |
74 |
| Boehringer Ingelheim International GmbH | 4701 |
60 |
| Hoffmann-La Roche Inc. | 3369 |
58 |
| Merck Patent GmbH | 5840 |
52 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3361 |
48 |
| Glaxo Group Limited | 4132 |
43 |
| Takeda Pharmaceutical Company Limited | 2703 |
42 |
| AstraZeneca AB | 2928 |
41 |
| Janssen Pharmaceutica N.V. | 3432 |
40 |
| The Regents of the University of California | 19803 |
39 |
| Glaxosmithkline Intellectual Property Development Limited | 753 |
39 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 629 |
35 |
| Jiangsu Hengrui Medicine Co., Ltd. | 706 |
34 |
| Bayer Pharma AG | 1061 |
33 |
| Sanofi | 4008 |
31 |
| Other owners | 7332 |